Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Post by wildbird1on Jul 11, 2021 10:24am
347 Views
Post# 33527571

Exact number of tests...

Exact number of tests...Many people are asking about the exact number of tests "conducted" or "sold" in Q2 2021.
Conducted = Screenpro was involved.
Sold = Screenpro was not involved.

In the Discord July 5,2021 M.Gunter said " There are revenue question I can not address. Please don't send in the revenue questions, as I can't address those here".
Meaning;
Giving us the exact numbers and type of tests for Q2 2021 could give us the necessary tools to calculate Q2 revenues(it is a revenue question).
We might have to wait for Q2 financial(end of August 2021) to find out the tests revenues.

Telemidicine demand explode...

TSXU:DOC(CloudMD) a telemidicine company.
In the last year (the Covid-19 year)
DOC SP year low was $0.54.
DOC SP year high was $3.43.
An increase in SP value of 540%.

I am not trying to compare DOC to DM(DM AI&Telemidicine combined concept is different from DOC).
It is just to show that in the last year because of the Covid-19 the demand for Telemidicine has increased. People have developed an interest in Telemidicine that will continue to grow after the Covid-19 crisis is over.
The timing of Datametrex acquisition of a Telemidicine company is good, and Datametrex has over $13 million in the bank to push its AI&Telemidicine combined new concept.
With the demand for Telemidicine increasing Datametrex telemidicine acquisition could generate good profit faster than we think.





<< Previous
Bullboard Posts
Next >>